Nobuhisa Akamatsu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Nobuhisa Akamatsu has a total of 317 co-authors. Here are the top co-authors by number of shared publications:
- Kiyoshi Hasegawa
Hepato–Biliary–Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
31 shared publications - Junichi Kaneko
Hepato-Biliary-Pancreatic Surgery, Department of Gastrointestinal Surgery, Tokai University, Hachioji Hospital, Tokyo, Japan
18 shared publications Kiyoshi Hasegawa
The University of Tokyo Hospital, Hepato-Biliary-Pancreatic Surgery Division and Artificial Organ and Transplantation Division, Department of Surgery, Japan
18 shared publications- Norihiro Kokudo
National Center for Global Health and Medicine
18 shared publications Norihiro Kokudo
Department of Surgery National Center for Global Health and Medicine Tokyo Japan
16 shared publicationsJunichi Kaneko
15 shared publications
Latest Publications
- 10 February 2026
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 32 (7) , 1027-1039
Early graft failure after adult living donor liver transplantation: A multicenter risk analysis and development of the early allograft failure in living donor liver transplantation (EAGLE-LDLT) model
Early allograft failure (EAF) after living donor liver transplantation (LDLT) remains a clinical challenge. Existing prediction models developed for deceased donor transplantation poorly apply to LDLT due to distinct surgical and physiological factors. This study identifies clinical determinants of EAF and develops an LDLT-specific prediction model. We conducted a multicenter retrospective cohort study from 17 high-volume LDLT centers (January 2016–December 2020) with external validation at a tertiary center in Saudi Arabia (January 2015–December 2022). The primary outcome was EAF (graft loss or patient death ≤90 d). Multivariable mixed-effects logistic regression identified preoperative/intraoperative risk factors. The EAGLE-LDLT model was constructed using postoperative laboratory values. Performance was compared against established models (EAD, MEAF, A2ALL) using ROC analysis and decision curve analysis. The development cohort included 2944 adult LDLT recipients (67.7% male; median age 55 y; median MELD 14) with a 5.5% EAF rate. External validation included 1020 recipients (median MELD 21, 6.7% EAF). Independent risk factors for EAF were MELD (OR 1.06, 95% CI 1.04–1.08), donor BMI (OR 1.05, 95% CI 1.00–1.10), portal vein thrombosis (OR 1.73, 95% CI 1.13–2.63), and hepaticojejunostomy (OR 1.58, 95% CI 1.06–2.36). The EAGLE-LDLT model incorporating peak ALT (>468 U/L), peak INR (>1.9), and bilirubin (>3.5 mg/dL) and INR (>1.3) at POD7, demonstrated superior discrimination (AUC=0.81) compared with MEAF (AUC=0.77, p =0.004), EAD (AUC=0.67, p p <0.001). EAGLE-LDLT achieved balanced sensitivity (75.0%) and specificity (73.7%), effectively stratifying patients into high-risk (15% of patients; 40.4% EAF incidence) and low-risk groups. Preoperative and intraoperative clinical factors predict EAF in LDLT. The EAGLE-LDLT model accurately identifies LDLT recipients at the highest risk for EAF postoperatively.
- 10 February 2026
- Published by Wolters Kluwer Health in Liver Transplantation
- Vol. 32 (7) , 1027-1039
Early graft failure after adult living donor liver transplantation: A multicenter risk analysis and development of the early allograft failure in living donor liver transplantation (EAGLE-LDLT) model
Early allograft failure (EAF) after living donor liver transplantation (LDLT) remains a clinical challenge. Existing prediction models developed for deceased donor transplantation poorly apply to LDLT due to distinct surgical and physiological factors. This study identifies clinical determinants of EAF and develops an LDLT-specific prediction model. We conducted a multicenter retrospective cohort study from 17 high-volume LDLT centers (January 2016–December 2020) with external validation at a tertiary center in Saudi Arabia (January 2015–December 2022). The primary outcome was EAF (graft loss or patient death ≤90 d). Multivariable mixed-effects logistic regression identified preoperative/intraoperative risk factors. The EAGLE-LDLT model was constructed using postoperative laboratory values. Performance was compared against established models (EAD, MEAF, A2ALL) using ROC analysis and decision curve analysis. The development cohort included 2944 adult LDLT recipients (67.7% male; median age 55 y; median MELD 14) with a 5.5% EAF rate. External validation included 1020 recipients (median MELD 21, 6.7% EAF). Independent risk factors for EAF were MELD (OR 1.06, 95% CI 1.04–1.08), donor BMI (OR 1.05, 95% CI 1.00–1.10), portal vein thrombosis (OR 1.73, 95% CI 1.13–2.63), and hepaticojejunostomy (OR 1.58, 95% CI 1.06–2.36). The EAGLE-LDLT model incorporating peak ALT (>468 U/L), peak INR (>1.9), and bilirubin (>3.5 mg/dL) and INR (>1.3) at POD7, demonstrated superior discrimination (AUC=0.81) compared with MEAF (AUC=0.77, p =0.004), EAD (AUC=0.67, p p <0.001). EAGLE-LDLT achieved balanced sensitivity (75.0%) and specificity (73.7%), effectively stratifying patients into high-risk (15% of patients; 40.4% EAF incidence) and low-risk groups. Preoperative and intraoperative clinical factors predict EAF in LDLT. The EAGLE-LDLT model accurately identifies LDLT recipients at the highest risk for EAF postoperatively.
- Open Access
- 1 February 2026
- Published by AME Publishing Company in HepatoBiliary Surgery and Nutrition
- Vol. 15 (1) , 8
Adult living-donor liver transplantation without simultaneous splenectomy
Original Article Adult living-donor liver transplantation without simultaneous splenectomy Nobuhisa Akamatsu, Kaito Fukuda, Yujiro Nishioka, Akinori Miyata, Akihiko Ichida, Yoshikuni Kawaguchi, Junichi Kaneko, Kiyoshi Hasegawa
- 1 February 2026
- Published by AME Publishing Company in HepatoBiliary Surgery and Nutrition
- Vol. 15 (1) , 8
Open AccessAdult living-donor liver transplantation without simultaneous splenectomy
Original Article Adult living-donor liver transplantation without simultaneous splenectomy Nobuhisa Akamatsu, Kaito Fukuda, Yujiro Nishioka, Akinori Miyata, Akihiko Ichida, Yoshikuni Kawaguchi, Junichi Kaneko, Kiyoshi Hasegawa
- 3 December 2025
- Published by Wiley in Journal of Hepato-Biliary-Pancreatic Sciences
- Vol. 33 (3) , 168-180
Association Between Time‐In‐Therapeutic Range of Calcineurin Inhibitor Trough Level and Short‐Term Outcomes of Recipients After Adult Living‐Donor Liver Transplantation
Background: Time‐in therapeutic range (TTR) is defined as the time a drug concentration remains within the therapeutic range. To explore the optimal management of calcineurin inhibitor (CNI), we investigated how TTR percentage (TTR%) in two different CNI protocols relates to short‐term outcomes after living‐donor liver transplantation (LDLT). Methods: TTR% was estimated for two different protocols in 352 adult LDLT recipients over 90 days in this retrospective, single‐center study. Short‐term outcomes were compared among the TTR% groups in each protocol. Results: Higher TTR% was associated with better acute rejection‐free survival: 96.2%, 86.1%, 74.7%, and 38.9% for TTR% ≥ 60%, ≥ 50%–< 60%, ≥ 40%–< 50%, and < 40%, in the low‐target protocol, respectively ( p < 0.001, log‐rank test); 73.7%, 74.3%, 63.6%, and 48.3%, in the high‐target protocol, respectively ( p = 0.003). The incidence of adverse events was similar among TTR% groups in each protocol. Multivariate analysis revealed higher TTR% was protective for rejection‐free survival, and this trend was particularly pronounced in the low‐target protocol. Conclusions: High TTR%, reflecting well‐controlled CNI levels, was associated with better outcomes after LDLT. The outcome of high TTR% in low‐target protocol seems better, but further prospective validation is warranted.
- 3 December 2025
- Published by Wiley in Journal of Hepato-Biliary-Pancreatic Sciences
- Vol. 33 (3) , 168-180
Association Between Time‐In‐Therapeutic Range of Calcineurin Inhibitor Trough Level and Short‐Term Outcomes of Recipients After Adult Living‐Donor Liver Transplantation
Background: Time‐in therapeutic range (TTR) is defined as the time a drug concentration remains within the therapeutic range. To explore the optimal management of calcineurin inhibitor (CNI), we investigated how TTR percentage (TTR%) in two different CNI protocols relates to short‐term outcomes after living‐donor liver transplantation (LDLT). Methods: TTR% was estimated for two different protocols in 352 adult LDLT recipients over 90 days in this retrospective, single‐center study. Short‐term outcomes were compared among the TTR% groups in each protocol. Results: Higher TTR% was associated with better acute rejection‐free survival: 96.2%, 86.1%, 74.7%, and 38.9% for TTR% ≥ 60%, ≥ 50%–< 60%, ≥ 40%–< 50%, and < 40%, in the low‐target protocol, respectively ( p < 0.001, log‐rank test); 73.7%, 74.3%, 63.6%, and 48.3%, in the high‐target protocol, respectively ( p = 0.003). The incidence of adverse events was similar among TTR% groups in each protocol. Multivariate analysis revealed higher TTR% was protective for rejection‐free survival, and this trend was particularly pronounced in the low‐target protocol. Conclusions: High TTR%, reflecting well‐controlled CNI levels, was associated with better outcomes after LDLT. The outcome of high TTR% in low‐target protocol seems better, but further prospective validation is warranted.
- Open Access
- 15 November 2024
- Published by Wiley in Journal of Hepato-Biliary-Pancreatic Sciences
- Vol. 32 (1) , 58-68
An artificial intelligence‐based recognition model of colorectal liver metastases in intraoperative ultrasonography with improved accuracy through algorithm integration
Background/Purpose: Contrast‐enhanced intraoperative ultrasonography (CE‐IOUS) is crucial for detecting colorectal liver metastases (CLM) during surgery. Although artificial intelligence shows potential in diagnostic systems, its application in CE‐IOUS is limited.Methods: This study aimed to develop an automatic tumor detection model using Mask region‐based convolutional neural network (Mask R‐CNN) for CE‐IOUS images. CE‐IOUS videos of the CLM from 121 patients were collected, generating ground truth data. A total of 2659 images were obtained. Two models were developed: the basic recognition model (BRM), which was trained on CE‐mode images, and the subtraction model (SM), which used images created by a subtraction algorithm that highlighted the differences in pixel values between the basic‐mode and CE‐mode images. The subtraction algorithm focuses on echogenicity differences. These two models were combined into a combination model (CM), which assessed outcomes using the prediction probabilities from both models.Results: The optimal epochs were determined by the maximum area under the curve (AUC), and the thresholds were calculated accordingly. BRM, SM, and CM achieved 89.4%, 86.6%, and 96.5% accuracy, respectively. CM outperformed the individual models, achieving an AUC of 0.99.Conclusions: A novel automated recognition model was developed for accurate CLM detection in CE‐IOUS by integrating image‐ and algorithm‐based models.
- 15 November 2024
- Published by Wiley in Journal of Hepato-Biliary-Pancreatic Sciences
- Vol. 32 (1) , 58-68
Open AccessAn artificial intelligence‐based recognition model of colorectal liver metastases in intraoperative ultrasonography with improved accuracy through algorithm integration
Background/Purpose: Contrast‐enhanced intraoperative ultrasonography (CE‐IOUS) is crucial for detecting colorectal liver metastases (CLM) during surgery. Although artificial intelligence shows potential in diagnostic systems, its application in CE‐IOUS is limited.Methods: This study aimed to develop an automatic tumor detection model using Mask region‐based convolutional neural network (Mask R‐CNN) for CE‐IOUS images. CE‐IOUS videos of the CLM from 121 patients were collected, generating ground truth data. A total of 2659 images were obtained. Two models were developed: the basic recognition model (BRM), which was trained on CE‐mode images, and the subtraction model (SM), which used images created by a subtraction algorithm that highlighted the differences in pixel values between the basic‐mode and CE‐mode images. The subtraction algorithm focuses on echogenicity differences. These two models were combined into a combination model (CM), which assessed outcomes using the prediction probabilities from both models.Results: The optimal epochs were determined by the maximum area under the curve (AUC), and the thresholds were calculated accordingly. BRM, SM, and CM achieved 89.4%, 86.6%, and 96.5% accuracy, respectively. CM outperformed the individual models, achieving an AUC of 0.99.Conclusions: A novel automated recognition model was developed for accurate CLM detection in CE‐IOUS by integrating image‐ and algorithm‐based models.
- Open Access
- 8 October 2024
- Published by Wiley in Pediatric Transplantation
- Vol. 28 (7) , e14869
Fatal Hyperacute Liver Failure due to Varicella Zoster Virus Immediately After Living‐Donor Liver Transplantation: A Case Report and Review of the Literature
Background: Although acute hepatitis caused by varicella zoster virus mostly develops in immunocompromised patients, hyperacute liver failure is very rare. To our knowledge, there are no previous reports on liver transplant patients.Methods: We report the first case of fatal hyperacute liver failure due to varicella zoster virus immediately after living‐donor liver transplantation without cutaneous lesions and review the literature.Result: The present case exhibited rapid development and progression of acute liver failure from postoperative days 11–13, despite being seropositive for varicella zoster virus but unvaccinated and on immunosuppression before transplantation. Especially in solid organ transplantation, only six cases of severe acute liver failure that included hepatic encephalopathy and/or impaired consciousness and sudden extremely high (> 4000 U/L) serum aspartate aminotransferase levels have been reported in heart, lung, and kidney transplant patients.Conclusions: Early diagnosis of hyperacute liver failure due to varicella zoster virus is challenging because the disease progresses rapidly and skin lesions are absent.
- 8 October 2024
- Published by Wiley in Pediatric Transplantation
- Vol. 28 (7) , e14869
Open AccessFatal Hyperacute Liver Failure due to Varicella Zoster Virus Immediately After Living‐Donor Liver Transplantation: A Case Report and Review of the Literature
Background: Although acute hepatitis caused by varicella zoster virus mostly develops in immunocompromised patients, hyperacute liver failure is very rare. To our knowledge, there are no previous reports on liver transplant patients.Methods: We report the first case of fatal hyperacute liver failure due to varicella zoster virus immediately after living‐donor liver transplantation without cutaneous lesions and review the literature.Result: The present case exhibited rapid development and progression of acute liver failure from postoperative days 11–13, despite being seropositive for varicella zoster virus but unvaccinated and on immunosuppression before transplantation. Especially in solid organ transplantation, only six cases of severe acute liver failure that included hepatic encephalopathy and/or impaired consciousness and sudden extremely high (> 4000 U/L) serum aspartate aminotransferase levels have been reported in heart, lung, and kidney transplant patients.Conclusions: Early diagnosis of hyperacute liver failure due to varicella zoster virus is challenging because the disease progresses rapidly and skin lesions are absent.
- Open Access
- 29 April 2024
- Published by Elsevier in American Journal of Transplantation
- Vol. 24 (10) , 1857-1867
A novel scoring system to predict short-term mortality after living donor liver transplantation for acute liver failure
- 29 April 2024
- Published by Elsevier in American Journal of Transplantation
- Vol. 24 (10) , 1857-1867
Open AccessA novel scoring system to predict short-term mortality after living donor liver transplantation for acute liver failure
- Open Access
- 1 April 2024
- Published by AME Publishing Company in Translational Gastroenterology and Hepatology
- Vol. 9, 23
Resection and reconstruction of the largest abdominal vein system (the inferior vena cava, hepatic, and portal vein): a narrative review
Background and Objective: As tumors invade major abdominal veins, surgical procedures are transformed from simple and basic to complicated and challenging. In this narrative review, we focus on what is currently known and not known regarding the technical aspects of major abdominal venous resection and its reconstruction, patency, and oncologic benefit in a cross-cutting perspective. Methods: A systematic literature search was performed in PubMed and Semantic Scholar from inception up to October 18, 2023. We reviewed 106 papers by title, abstract, and full text regarding resection or reconstruction of the inferior vena cava, hepatic vein confluence, portal vein (PV), and middle hepatic vein (MHV) tributaries in living donor liver transplantation (LDLT) in a cross-cutting perspective. Key Content and Findings: The oncologic benefit of aggressive hepatic vein resection with suitable reconstruction against adenocarcinoma remains unclear, and further studies are required to clarify this point. A superior mesenteric/PV resection is now a universal, indispensable, and effective procedure for pancreatic ductal adenocarcinoma. Although many case series using tailor-made autologous venous grafts have been reported, not only size mismatch but also additional surgical incisions and a longer operation time remain obstacles for venous reconstruction. The use of autologous alternative tissue remains only an alternative procedure because the patency rate of customized tubular conduit type to interpose or replace the resected vein is not known. Unlike arterial replacement, venous replacement using synthetic vascular grafts is still rarely reported and there are several inherent limitations except for reconstruction of tributaries of MHV in LDLT. Conclusions: Various approaches to abdominal vein resection and replacement or reconstruction are technically feasible with satisfactory results. Synthetic vascular grafts may be appropriate but have a certain rate of complications.
- 1 April 2024
- Published by AME Publishing Company in Translational Gastroenterology and Hepatology
- Vol. 9, 23
Open AccessResection and reconstruction of the largest abdominal vein system (the inferior vena cava, hepatic, and portal vein): a narrative review
Background and Objective: As tumors invade major abdominal veins, surgical procedures are transformed from simple and basic to complicated and challenging. In this narrative review, we focus on what is currently known and not known regarding the technical aspects of major abdominal venous resection and its reconstruction, patency, and oncologic benefit in a cross-cutting perspective. Methods: A systematic literature search was performed in PubMed and Semantic Scholar from inception up to October 18, 2023. We reviewed 106 papers by title, abstract, and full text regarding resection or reconstruction of the inferior vena cava, hepatic vein confluence, portal vein (PV), and middle hepatic vein (MHV) tributaries in living donor liver transplantation (LDLT) in a cross-cutting perspective. Key Content and Findings: The oncologic benefit of aggressive hepatic vein resection with suitable reconstruction against adenocarcinoma remains unclear, and further studies are required to clarify this point. A superior mesenteric/PV resection is now a universal, indispensable, and effective procedure for pancreatic ductal adenocarcinoma. Although many case series using tailor-made autologous venous grafts have been reported, not only size mismatch but also additional surgical incisions and a longer operation time remain obstacles for venous reconstruction. The use of autologous alternative tissue remains only an alternative procedure because the patency rate of customized tubular conduit type to interpose or replace the resected vein is not known. Unlike arterial replacement, venous replacement using synthetic vascular grafts is still rarely reported and there are several inherent limitations except for reconstruction of tributaries of MHV in LDLT. Conclusions: Various approaches to abdominal vein resection and replacement or reconstruction are technically feasible with satisfactory results. Synthetic vascular grafts may be appropriate but have a certain rate of complications.
- Open Access
- 28 February 2024
- Published by Elsevier in American Journal of Transplantation
- Vol. 24 (7) , 1233-1246
Biliary complications after adult-to-adult living-donor liver transplantation: An international multicenter study of 3633 cases
- 28 February 2024
- Published by Elsevier in American Journal of Transplantation
- Vol. 24 (7) , 1233-1246
Open AccessBiliary complications after adult-to-adult living-donor liver transplantation: An international multicenter study of 3633 cases
- Open Access
- 1 February 2024
- Published by AME Publishing Company in HepatoBiliary Surgery and Nutrition
- Vol. 13 (1) , 143-146
Liver transplantation for primary sclerosing cholangitis—morbidities including disease recurrence
Liver transplantation for primary sclerosing cholangitis—morbidities including disease recurrence
- 1 February 2024
- Published by AME Publishing Company in HepatoBiliary Surgery and Nutrition
- Vol. 13 (1) , 143-146
Open AccessLiver transplantation for primary sclerosing cholangitis—morbidities including disease recurrence
Liver transplantation for primary sclerosing cholangitis—morbidities including disease recurrence
- Open Access
- 8 December 2023
- Published by Wiley in Journal of Hepato-Biliary-Pancreatic Sciences
- Vol. 31 (4) , 243-250
A data‐informed timeline for hospital discharge with a reasonably low risk of unplanned readmission after open and minimally invasive liver resections
Background: Postoperative complications following liver resection remain high, ranging from 20% to 50%. Patients are hospitalized for a certain period of time following liver resection because of the risk of postoperative complications. We hypothesized that the risk of complications decreases with each complication‐free postoperative day after open and minimally invasive liver resections and can be stratified using a recently reported three‐level complexity classification.Methods: Patients undergoing first liver resection without concomitant other organ resections between 2006 and 2019 were included. The three‐level complexity classification was used to categorize liver resection procedures into grades I–III. We assessed the rate of cumulative postoperative complications from the time of liver resection to the time of post‐hepatectomy complications (≥ Clavien–Dindo grade II).Results: Of the 911 patients included, 200 underwent resection of grade I procedures, 185 underwent resection of grade II procedures, and 526 underwent resection of grade III procedures. The risks of post‐hepatectomy complications changed over time and were stratified by surgical complexity. For patients at the time of liver resection, the estimated 30‐day complication rate was 21.8% for open grade I resection, 26.7% for open grade II resection, 38.4% for open grade III resection, 8.6% for laparoscopic grade I resection, and 12.5% for laparoscopic grade II resection. For patients without complications at 7 days, the estimated 30‐day complication rate decreased to 2.1% for open grade I, 9.2% for open grade II, 17.6% for open grade III, 1.3% for laparoscopic grade I, and 4.5% for laparascopic grade II.Conclusions: The post‐hepatectomy complication risks were stratified by surgical complexity, liver resection approach, and the period without complication after liver resection.
- 8 December 2023
- Published by Wiley in Journal of Hepato-Biliary-Pancreatic Sciences
- Vol. 31 (4) , 243-250
Open AccessA data‐informed timeline for hospital discharge with a reasonably low risk of unplanned readmission after open and minimally invasive liver resections
Background: Postoperative complications following liver resection remain high, ranging from 20% to 50%. Patients are hospitalized for a certain period of time following liver resection because of the risk of postoperative complications. We hypothesized that the risk of complications decreases with each complication‐free postoperative day after open and minimally invasive liver resections and can be stratified using a recently reported three‐level complexity classification.Methods: Patients undergoing first liver resection without concomitant other organ resections between 2006 and 2019 were included. The three‐level complexity classification was used to categorize liver resection procedures into grades I–III. We assessed the rate of cumulative postoperative complications from the time of liver resection to the time of post‐hepatectomy complications (≥ Clavien–Dindo grade II).Results: Of the 911 patients included, 200 underwent resection of grade I procedures, 185 underwent resection of grade II procedures, and 526 underwent resection of grade III procedures. The risks of post‐hepatectomy complications changed over time and were stratified by surgical complexity. For patients at the time of liver resection, the estimated 30‐day complication rate was 21.8% for open grade I resection, 26.7% for open grade II resection, 38.4% for open grade III resection, 8.6% for laparoscopic grade I resection, and 12.5% for laparoscopic grade II resection. For patients without complications at 7 days, the estimated 30‐day complication rate decreased to 2.1% for open grade I, 9.2% for open grade II, 17.6% for open grade III, 1.3% for laparoscopic grade I, and 4.5% for laparascopic grade II.Conclusions: The post‐hepatectomy complication risks were stratified by surgical complexity, liver resection approach, and the period without complication after liver resection.